Internal Medicine, Rheumatology · Modesto, CA
NPI
1124435003
Since 2014
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
600 Coffee Rd
Modesto, CA, 95355
Phone (209) 550-4730
Groups this clinician bills Medicare through
Medicare paid, 2024
$234K
5,614 services
Medicare patients, 2024
502
Average age 72
Drug cost, 2024
$4.9M
4,613 prescriptions
Company payments, 2025
$3,389
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thein Swe was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 1,906 times for 165 patients. In total Thein Swe billed 5,614 services in 22 codes, and Medicare paid $234K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,906 | 165 | $0.78 | $1,478 |
| 99214 Office E&M - Established | Office | 1,088 | 396 | $92.25 | $100K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 527 | 290 | $13.06 | $6,885 |
| 99215 Office E&M - Established | Office | 476 | 247 | $135.01 | $64K |
| 20610 Joint Injection | Office | 373 | 163 | $46.81 | $17K |
| 20552 Musculoskeletal | Office | 164 | 102 | $21.80 | $3,575 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 140 | 25 | $0.53 | $74.66 |
| 99205 Office E&M - New | Office | 77 | 77 | $162.30 | $12K |
| 96372 Injection Administration | Office | 41 | 30 | $11.55 | $473 |
| 99213 Office E&M - Established | Office | 37 | 25 | $64.07 | $2,371 |
| 99204 Office E&M - New | Office | 27 | 27 | $127.54 | $3,444 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $136.32 | $1,500 |
By year: 2022 $199K for 6,734 services; 2023 $228K for 6,167 services; 2024 $234K for 5,614 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thein Swe prescribed most often to Medicare patients was Prednisone, with 927 prescriptions and refills. In total Thein Swe wrote 4,613 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 927 | 1,802 | 330 | $6,222 |
| Hydroxychloroquine Sulfate Generic | 735 | 1,560 | 203 | $34K |
| Methotrexate Methotrexate Sodium | 542 | 1,255 | 170 | $13K |
| Gabapentin Generic | 359 | 645 | 96 | $4,486 |
| Enbrel Sureclick Etanercept | 251 | 251 | 31 | $1.8M |
| Meloxicam Generic | 203 | 291 | 73 | $579 |
| Leflunomide Generic | 155 | 340 | 56 | $7,292 |
| Folic Acid Generic | 150 | 440 | 51 | $1,612 |
| Allopurinol Generic | 114 | 249 | 28 | $1,010 |
| Humira(Cf) Pen Adalimumab | 104 | 113 | 16 | $783K |
| Duloxetine Hcl Generic | 104 | 156 | 31 | $1,488 |
| Sulfasalazine Generic | 82 | 170 | 18 | $1,989 |
| Diclofenac Sodium Generic | 78 | 84 | 30 | $1,504 |
| Ibuprofen Generic | 53 | 78 | 13 | $429 |
| Methylprednisolone Generic | 50 | 68 | Under 11 | $694 |
Brand drugs: - claims; generic drugs: 3,903 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thein Swe $3,389 ($3,389 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $833.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 48 | $833 |
| Novartis Pharmaceuticals Corporation NVS | 25 | $500 |
| Janssen Biotech, Inc. JNJ | 26 | $415 |
| GlaxoSmithKline, LLC. GSK | 13 | $309 |
| Pfizer Inc. PFE | 11 | $280 |
| UCB, Inc. UCB.BR | 9 | $279 |
| Amgen Inc. AMGN | 14 | $242 |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $213 |
| Lilly USA, LLC LLY | 11 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $95.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.